Evidence map›Paper›PMID 39322610›Full record

ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2024

Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical excision procedure (LEEP) specimens.

Sydney Chambule, Ricardina Rangeiro, Samantha Batman, Eva Lathrop, Nafissa Osman, Andrea Neves, Arlete A N Mariano, Jean Claude Nkundabatware, Carla Carrilho, Eliane C S Monteiro and 11 more

Abstract read
In one paragraph

Article in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sydney ChambuleUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-2955-7852
Ricardina RangeiroObstetrics and Gynecology, Hospital Central de Maputo, Maputo, Mozambique.
Samantha BatmanGynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0003-0250-2322
Eva LathropGlobal Medical Director, Population Services International, Washington, District of Columbia, USA.
Nafissa OsmanObstetrics and Gynecology, Universidade Eduardo Mondlane, Maputo, Mozambique.ORCID 0000-0001-5832-1630
Andrea NevesObstetrics and Gynecology, Hospital Geral e Centro de Saúde José Macamo, Maputo, Mozambique.ORCID 0009-0009-3644-6657
Arlete A N MarianoObstetrics and Gynecology, Hospital Geral e Centro de Saúde de Mavalane, Maputo, Mozambique.
Jean Claude NkundabatwareObstetrics and Gynecology, Hospital Provincial de Xai-Xai, Xai-Xai, Mozambique.
Carla CarrilhoAnatomical Pathology, Universidade Eduardo Mondlane, Maputo, Mozambique.ORCID 0000-0003-0208-7309
Eliane C S MonteiroPathology, Hospital Geral e Centro de Saúde de Mavalane, Maputo, Mozambique.
Rosita Paulo MugoloPathology, Hospital Central de Maputo, Maputo, Mozambique.
Joseph P ThomasDepartment of Oncology Care and Research Information Systems, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jennifer CarnsBioengineering, Rice University, Houston, Texas, USA.ORCID 0000-0002-4026-0558
Viviane AndradeResearch, ICON Strategic Solutions, São Paulo, Brazil.
Hira AtifObstetrics and Gynecology, Hospital Central de Maputo, Maputo, Mozambique.ORCID 0009-0007-7727-4922
Ellen BakerGynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-0743-1378
Bryan M FellmanDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rebecca Richards-KortumBioengineering, Rice University, Houston, Texas, USA.ORCID 0000-0003-2347-9467
Kathleen M SchmelerGynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-9670-4189
Cesaltina LorenzoniPathology, Hospital Central de Maputo, Maputo, Mozambique.
Mila Pontremoli SalcedoGynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Mpsalcedo@mdanderson.org.ORCID 0000-0002-6375-0736

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectivesAs cervical cancer screening programs are implemented and expanded, an increasing number of women require loop electrosurgical excision procedure (LEEP) for treatment of pre-invasive cervical disease. Our objective was to describe the pathological results of LEEP specimens performed as part of the MULHER study and identify factors associated with positive LEEP margins.

methodsThe MULHER study enrolled 9014 women who underwent HPV testing followed by visual assessment for treatment (VAT) using visual inspection with acetic acid (VIA) and thermal ablation for those with positive results. Participants with lesions ineligible for ablation underwent LEEP. Pathology reports were reviewed for specimen size/volume, number of fragments, pathological diagnosis and margin status. Multivariable regression analysis was performed to identify variables associated with positive LEEP margins.

results169 participants underwent LEEP. The median age was 38 years (range 30-49). 65.1% were women living with HIV. Pathological diagnosis was available for 154 patients and included cancer (n=6, 3.9%); cervical intraepithelial neoplasia (CIN) 2/3 (n=75, 48.7%); CIN 1 (n=67, 43.5%); and normal/benign findings (n=6,3.9%). 31.8% of LEEP specimens were removed in more than one fragment. The mean specimen volume was 2.9 cm

conclusionOur results showed a high number of LEEP specimens with positive margins. Additional evaluation is needed to better understand the characteristics of precancerous cervical lesions in this high-risk population. As cervical cancer screening programs are scaled in Mozambique and other lower-resource countries, there is a need to train providers to perform high-quality LEEP and for accurate and timely pathological interpretation.

Indexed as

Early Detection of CancerElectrosurgeryUterine Cervical NeoplasmsAdultFemaleHumansMargins of ExcisionMiddle AgedMozambiqueUterine Cervical DysplasiaCervical Cancer

Identifiers

PMID39322610
PMCPMC12450301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.